Get my own profile
Public access
View all39 articles
2 articles
available
not available
Based on funding mandates
Co-authors
Ulf NorinderMTM Research Centre, School of Science and Technology, Örebro University, Örebro, SwedenVerified email at oru.se
Andreas BenderUniversity of Cambridge; Pangea Bio; Universitatea Babeș-Bolyai; UMF ClujVerified email at cam.ac.uk
Mats LarhedProfessor in Medicinal Chemistry, Uppsala UniversityVerified email at ilk.uu.se
Paul V. FishEndLyz Therapeutics UK & UCLVerified email at ucl.ac.uk
Jonas SävmarkerScientific Director, Orexo ABVerified email at orgfarm.uu.se
E Yvonne JonesThe Sir Andrew McMichael Professor of Structural Immunology, University of OxfordVerified email at strubi.ox.ac.uk
Yuguang ZhaoOxford UniversityVerified email at strubi.ox.ac.uk
Avid M. AfzalAstraZenecaVerified email at astrazeneca.com
Benjamin N AtkinsonSamsara TherapeuticsVerified email at samsaratherapeutics.com
Amy MonaghanMSDVerified email at msd.com
Ola SpjuthProfessor at Department of Pharmaceutical Biosciences, Uppsala UniversityVerified email at farmbio.uu.se
Jonas RydfjordResearcher, Uppsala UniversitetVerified email at ilk.uu.se
Prof G.R. LaddsVerified email at cam.ac.uk
Jean-Paul Vincentsenior group leader the francis crick instituteVerified email at crick.ac.uk
paul whitingVerified email at ucl.ac.uk
Lorenza MagnoSenior Research Fellow, University College LondonVerified email at ucl.ac.uk
Lewis MervinAstraZenecaVerified email at astrazeneca.com
Leen KalashGlaxoSmithKlineVerified email at gsk.com
Elliott BayleUniversity College LondonVerified email at ucl.ac.uk
Reinis Reinholds RuzaPhD Student, University of OxfordVerified email at strubi.ox.ac.uk